VICINI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 2.944
EU - Europa 2.081
AS - Asia 1.765
SA - Sud America 244
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 45
OC - Oceania 6
AN - Antartide 1
Totale 7.145
Nazione #
US - Stati Uniti d'America 2.859
IT - Italia 811
SG - Singapore 525
CN - Cina 503
GB - Regno Unito 433
BR - Brasile 184
VN - Vietnam 168
HK - Hong Kong 166
SE - Svezia 155
IE - Irlanda 148
DE - Germania 128
BD - Bangladesh 108
FI - Finlandia 82
RU - Federazione Russa 65
KR - Corea 62
FR - Francia 54
IN - India 51
CA - Canada 42
ID - Indonesia 42
NL - Olanda 39
UA - Ucraina 38
MX - Messico 27
AR - Argentina 23
TR - Turchia 21
JP - Giappone 20
BG - Bulgaria 16
BE - Belgio 13
ES - Italia 13
AE - Emirati Arabi Uniti 12
AT - Austria 12
LT - Lituania 12
PL - Polonia 12
ZA - Sudafrica 12
CO - Colombia 11
MY - Malesia 11
MK - Macedonia 10
PH - Filippine 10
CL - Cile 9
IQ - Iraq 9
PK - Pakistan 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
GR - Grecia 7
AU - Australia 6
CH - Svizzera 6
EC - Ecuador 6
KE - Kenya 6
VE - Venezuela 6
MA - Marocco 5
TH - Thailandia 5
TN - Tunisia 5
UZ - Uzbekistan 5
AL - Albania 4
CR - Costa Rica 4
ET - Etiopia 4
JO - Giordania 4
NG - Nigeria 4
RS - Serbia 4
CY - Cipro 3
DO - Repubblica Dominicana 3
EG - Egitto 3
IL - Israele 3
BH - Bahrain 2
HN - Honduras 2
IR - Iran 2
IS - Islanda 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
RO - Romania 2
A1 - Anonimo 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
HT - Haiti 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MD - Moldavia 1
MG - Madagascar 1
MN - Mongolia 1
MQ - Martinica 1
MZ - Mozambico 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PR - Porto Rico 1
Totale 7.084
Città #
Singapore 359
Ashburn 348
Santa Clara 332
Southend 303
Fairfield 184
San Jose 169
Chandler 164
Hong Kong 163
Hefei 158
Dublin 140
Ann Arbor 103
Woodbridge 103
Beijing 92
Houston 79
Nyköping 77
Seattle 76
Los Angeles 75
Council Bluffs 73
Wilmington 69
Dearborn 62
Jacksonville 62
London 62
Milan 60
Bologna 58
Ho Chi Minh City 58
New York 58
Cambridge 57
Modena 57
Seoul 55
Helsinki 52
The Dalles 47
Hanoi 43
Rome 38
Jakarta 36
Chicago 33
Munich 31
Shanghai 30
Reggio Emilia 27
San Diego 25
Boardman 24
Lauterbourg 19
Bremen 18
Orem 18
Dallas 17
São Paulo 17
Buffalo 16
Eugene 16
Frankfurt am Main 16
Moscow 16
Princeton 16
Sofia 16
Turin 16
Turku 16
Bari 15
Toronto 15
Florence 14
Tokyo 14
Brussels 12
Parma 12
Mexico City 11
Palermo 11
Redwood City 11
Amsterdam 10
Hillsboro 10
Nuremberg 10
Warsaw 10
Izmir 9
Kent 9
Lappeenranta 9
Redondo Beach 9
Denver 8
Falls Church 8
Haiphong 8
Salt Lake City 8
Atlanta 7
Belo Horizonte 7
Chennai 7
Poplar 7
Boston 6
Buenos Aires 6
Chengdu 6
Ferrara 6
Fulham 6
Kuala Lumpur 6
Las Vegas 6
Monterrey 6
Montreal 6
Paris 6
Phoenix 6
Stockholm 6
Tampa 6
Brasília 5
Brescia 5
Brooklyn 5
Catania 5
Da Nang 5
Fremont 5
Hangzhou 5
Kunming 5
Naples 5
Totale 4.633
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 492
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVO 492
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 416
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 408
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 386
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 358
"It's All COVID's Fault!": Symptoms of Distress among Workers in an Italian General Hospital during the Pandemic 341
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 309
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 284
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 273
Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial 273
PREVALENCE OF NODE NEGATIVE AND SMALL SIZE TUMORS IN A NATIONAL, RANDOMISED, PHASE III ADJUVANT TRIAL IN HER2 + EARLY BREAST CANCER (SHORT-HER STUDY) 271
Preoperative carboplatin-paclitaxel-bevacizumab in triple negative breast cancer: Final results of the phase II CA.Pa.Be study 266
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol 261
Biomarker expression and survival after primary chemotherapy for breast cancer. 250
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial 242
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVE: ANALISI PRELIMINARE DELLE TOSSICITA’ 217
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 210
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial 210
Rapamycin treatment for amyotrophic lateral sclerosis protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 199
Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial 191
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 180
Physical activity practiced at a young age is associated with a less severe subsequent clinical presentation in facioscapulohumeral muscular dystrophy 176
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials 153
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 150
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 137
Totale 7.145
Categoria #
all - tutte 26.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022372 0 31 26 12 10 26 16 31 51 23 103 43
2022/2023651 53 61 40 46 57 62 16 50 195 12 27 32
2023/2024577 31 26 33 57 54 54 63 73 36 46 51 53
2024/20251.426 37 25 45 110 254 230 101 78 155 51 129 211
2025/20262.608 216 103 191 284 389 128 337 110 219 293 229 109
2026/2027111 94 17 0 0 0 0 0 0 0 0 0 0
Totale 7.145